Clinical Information

PULsecath mechanicaL Support Evaluation (PULSE) – ongoing trial

Prof.Dr. Nicolas van Mieghem, Erasmus Medical Center Brief Summary: The objective of this study is to determine ventricular loading conditions during and after PulseCath®  iVAC 2L support, and assess its impact on specific load dependent humoral factors and cardiac enzymes. These specific patterns are so far unknown and will be compared with the validated FDA-cleared and CE marked Impella CP. Three cases with Impella CP will be performed in this study to obtain the exact same measurements for comparing purposes. For more information about this trial, please follow this link.

Head-to-Head Comparison of a Pulsatile and a Continuous Flow Left Ventricular Assist Device in High-Risk PCI Setting: iVAC2L Versus Impella 2.5. September 2019

Alexander Samol,1 Blerim Luani,2 Sven Kaese,3 Marcus Wiemer3 1Johannes Wesling University Hospital, Department of Cardiology and Critical Care Medicine, Minden, Germany; 2 Ruhr University Bochum, Minden, Germany; 3 Johannes Wesling University Hospital Minden, Minden, Germany Read here the full Jacc Publication B319.full Jacc Publication Ivac vs Impella

Head to head comparison of a pulsatile and a continuous flow left ventricular assist device in high-risk PCI setting – iVAC 2L vs. Impella

Head to head comparison of a pulsatile and a continuous flow left ventricular assist device in high-risk PCI setting – iVAC 2L vs. Impella Alexander Samol1, Stefanie Schmidt1, Blerim Luani1, Sven Kaese1, Melanie Zeyse1, Marcus Wiemer1 1Department of Cardiology and Critical Care Medicine, Johannes Wesling University Hospital, Minden, Germany Click to download study  EuroPCRposter Ivac Vs Impella